Baiyunshan (600332.SH) subsidiary plans to transfer 100% of Zhejiang Medical Engineering's shares for 501 million yuan

According to the Zhitong Finance App, Baiyunshan (600332.SH) announced that Guangzhou Pharmaceutical, a holding subsidiary of the company, plans to transfer 100% of the shares of Haizheng Pharmaceutical Co., Ltd. (“Zhejiang Medical”) through public delisting, with a transfer price of 501 million yuan.

Zhejiang Medical Engineering is located in the Yangtze River Delta region. The pharmaceutical market is well developed, and it is one of the top 6 high-quality pharmaceutical distribution enterprises in Zhejiang Province. At the same time, Zhejiang Medical Engineering has always been deeply involved in the pharmaceutical market in Zhejiang Province and has accumulated rich customer resources. The last year's annual sales revenue was more than 4 billion yuan, and it has good prospects. The transaction will help Guangzhou Pharmaceutical gain a mature customer network in Zhejiang Province and surrounding regions, further optimize Guangzhou Pharmaceutical's industrial layout in East China, enhance the breadth and depth of coverage of the domestic terminal market, and meet the company's strategic plans for the long-term development of Guangzhou Pharmaceutical.